Sessile serrated adenoma: A brief history and current status

Critical Reviews in Oncogenesis

Volumn 12, Issue 1-2, 2006, Pages 27-39

  Torlakovic, Emina Emilia ^a   Snover, Dale C ^b  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b FAIRVIEW SOUTHDALE HOSPITAL   (United States)

Author keywords

Colon; Pathology; Sessile serrated adenoma

Indexed keywords

APOPTOSIS; ASCENDING COLON; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; COLORECTAL CARCINOMA; CPG ISLAND; DESCENDING COLON; DISEASE COURSE; DNA DAMAGE; FOLLOW UP; GASTROINTESTINAL POLYPOSIS; GOBLET CELL; HUMAN; INTESTINE POLYP; LARGE INTESTINE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; REVIEW; SESSILE SERRATED ADENOMA;

EID: 33749322730     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v12.i1-2.30     Document Type: Review

References (55)

1. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-37.
2. Teoh HH, Delahunt B, Isbister WH. Dysplastic and malignant areas in hyperplastic polyps of the large intestine. Pathology. 1989;21:138-42.
3. Cooper HS, Patchefsky AS, Marks G. Adenomatous and carcinomatous change within hyperplastic colonic epithelium. Dis Colon Rectum. 1979;22:152-6.
4. Franzin G, Novelli P. Adenocarcinoma occurring in a hyperplastic (metaplastic) polyp of the colon. Endoscopy. 1982;14:28-30.
5. Franzin G, Zamboni G, Scarpa A, Dina R, Iannucci A, Novelli P. Hyperplastic (metaplastic) polyps of the colon. A histologic and histochemical study. Am J Surg Pathol. 1984;8:687-98.
6. Estrada RG, Spjut HJ. Hyperplastic polyps of the large bowel. Am J Surg Pathol 1980;4:127-33.
7. Urbanski SJ, Kossakowska AE, Marcon N, Bruce WR. Mixed hyperplastic adenomatous polyps - an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol. 1984;8:551-6.
8. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 1996;110:748-55.
9. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65-81.
10. Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, Hillon P. Adenoma - carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer. 1992;69:883-8.
11. Lynch HT, Smyrk T, Jass JR. hereditary nonpolyposis colorectal cancer and colonic adenomas> aggressive adenomas? Semin Surg Oncol. 1995;11:406-10.
12. Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol. 2001;193:283-5.
13. Jass JR. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer. 2004;3:93-100.
14. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristic of serrated polyps of colorectum. Histopathology. 2005;47:32-40.
15. Jass JR, Iino H, Ruszkiewicz A, Painter D, Solomon MJ, Koorey DJ, Cohn D, Furlong KL, Walsh MD, Palazzo J, Edmonston TB, Fishel R, Young J, Leggett BA.. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut. 2000;47:43-9
16. Highchi T, Jass JR. My approach to serrated polyps of the colorectum. J Clin Pathol. 2004;57:682-6,
17. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778-96.
18. Jass JR. Hyperplastic-like polyps as precursors of micorsatellite- unstable colorectal cancer. Am J Clin Pathol 2003;119:773-5.
19. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine. Am J Clin Pathol. 2005;124:380-91.
20. Williams GT, Arthur JF, Bussey HJ, Morson BC. Metaplastic polyps and polyposis of the colorectum. Histopathology. 1980;4:155-70.
21. Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005;166:1069-75.
22. Ferrandez A, Samowitz W, DiSario JA, Burt RW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol. 2004;99:2012-8.
23. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol. 2004;99:1779-84.
24. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum. 2004;47:2101-4.
25. Oberschmid BI, Dietmaier W, Hartmann A, Dahl E, Klopocki E, Beatty BG, Hyman NH, Blaszyk H. Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome. Arch Pathol Lab Med. 2004;128:967-73.
26. Bengoechea O, Martinez-Penuela JM, Larrinaga B, Valerdi J, Borda F. Hyperplastic polyposis of the colorectum and adenocarcinoma in a 24-year-old man. Am J Surg Pathol. 1987;11:323-7.
27. McCann BG. A case of metaplastic polyposis of the colon associated with focal adenomatous change and metachronous adenocarcinomas. Histopathology. 1988;13:700-2.
28. Hawkins NJ, Ward RL: Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001;93:1307-13.
29. Jass JR, Cottier DS, Pokos V, Parry S, Winship IM: Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology. 1997;29:28-33.
30. Iino H, Jass JR, Simms LA, Young J, Leggett B, Ajioka Y, Watanabe H: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol. 1999;52:5-9.
31. Jass JR, Iino H, Ruszkiewicz A, Painter D, Solomon MJ, Koorey DJ, Cohn D, Furlong KL, Walsh MD, Palazzo J, Edmonston TB, Fishel R, Young J, Leggett BA: Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut. 2000;47:43-9
32. Rashid A, Houlihan PS, Booker S, Peterson GM, Giardiello FM, Hamilton SR: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology. 2000;119:323-332.
33. O'Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, Swan N. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28:423-34.
34. Baker K, Zhang Y, Jin C, Jass JR. Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol. 2004;57:1089-93.
35. Ladas SD, Kitsanta P, Triantafyllou K, Tzathas C, Spiliadi C, Raptis SA. Cell turnover of serrated adenomas. J Pathol. 2005;206:62-7.
36. Wynter CV, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut. 2004;53:573-80.
37. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452-9.
38. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 2004;444:213-23.
39. Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, Shaw NJ, Johnston DI, Clark AJ, Reznek RH, Grossman AB, Savage MO. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf). 2004;61:553-9.
40. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol. 2000;156:595-605.
41. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96:8681-6.
42. Hao CY, Moore DH, Wong P, Bennington JL, Lee NM, Chen LC. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer. Clin Cancer Res. 2005 Feb;11:1400-7.
43. Oh K, Redston M, Odze RD. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol. 2005;36:101-11.
44. Karam SM. Lineage commitment and maturation of epithelial cells in the gut. Front Biosci. 1999;4:D286-98.
45. Gervaz P, Bucher P and Morel P. Two colons - two cancers: Paradigm shift and clinical implications. J Surg Oncol. 2004;88: 261-6.
46. Sato M, Ahnen D. Regional variability of colonocyte growth and differentiation in the rat. Anat Rec. 1992;233:409-14.
47. Potten CS. Structure, function and proliferative organization of the mammalian gut. In: Potten CS, Hendry JH, editors. Radiation and Gut. Amsterdam: Elsevier Science 1995; p. 1-31.
48. Potten CS. Extreme sensitivity of some intestinal crypts cells to X and irradiation. Nature. 1977;269:518-21.
49. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 1994;54:614-7.
50. Potten CS, Grant HK. The relationship between ionizing radiation induced apoptosis and stem cells in the small and large intestine. Brit J Cancer. 1998;78:993-1004.
51. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Nakayama K, Hickman JA. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci. 1995;108:2261-71.
52. Potten CS. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci. 1998;353:821-30.
53. Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv. 2004;59:368-78.
54. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, Palazzo J, Fiane B, Lovslett K, Burger C, Voorhorst F, Verheijen RH. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103:2304-12.
55. Carr NJ, Sobin LH. Unusual tumors of the appendix and pseudomyxoma peritonei. Semin Diagn Pathol. 1996;13:314-25.